Day: November 5, 2021

Relief Reports U.S. Collaboration Partner’s Emergency Use Authorization Request for ZYESAMI/RLF-100 (aviptadil) for Patients with Critical COVID-19 with Respiratory Failure was Declined by U.S. FDA

GENEVA, SWITZERLAND / ACCESSWIRE / November 5, 2021 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF) ("Relief"), a biopharmaceutical company seeking to...

Prescryptive Health Introduces MyRx.io, a “Pharmacy on Your Phone,” Allowing Consumers to Own Their Prescriptions for the First Time

REDMOND, Wash., Nov. 4, 2021 /PRNewswire/ -- Prescryptive Health, a healthcare technology company empowering consumers, announced today the nationwide availability of MyRx.io, a...

error: Content is protected !!